Formulating Hope for Hard-to-Treat Patients.
At Handa, we collaborate with our partners to turn formulation science into new therapies for patients that today’s treatments leave behind.
At Handa Pharma, we harness the full transformative power of formulation science, creating precision medicines that deliver hope for hard-to-treat patients.
Product Announcement.
Product Announcement.
An orally disintegrating tablet advancing care in relapsing multiple sclerosis.
Who We Are.
Handa Pharma develops stable, effective, high-quality prescription medications to serve challenging, high-barrier markets.
These are the spaces where Handa delivers value and a durable advantage for patients, partners, and our team. Where we fully leverage our deep knowledge and experience navigating pharma’s complex R&D, marketing, licensing, and regulatory environment.
In the U.S. and China, two of the world’s largest pharmaceutical markets, Handa shepherds complex products from concept, through FDA review and approval, to successful commercialization and adoption.
Handa is headquartered in the San Francisco Bay Area, with a global R&D hub in Taiwan.
Our four wholly owned subsidiaries are:
- Handa Pharmaceuticals, LLC
- Handa Neuroscience, LLC
- Handa Oncology, LLC
- Handa Therapeutics, LLC
News.
Keep up-to-date with the latest news about Handa Pharma for media updates for investors, scientists and patients.